Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
HIF-1 promotes murine breast cancer brain metastasis by increasing production of integrin β3–containing extracellular vesicles
Yongkang Yang, Chelsey Chen, Yajing Lyu, Olesia Gololobova, Xin Guo, Tina Yi-Ting Huang, Vijay Ramu, Varen Talwar, Elizabeth E. Wicks, Shaima Salman, Daiana Drehmer, Dominic Dordai, Qiaozhu Zuo, Kenneth W. Witwer, Kathleen L. Gabrielson, Gregg L. Semenza
Yongkang Yang, Chelsey Chen, Yajing Lyu, Olesia Gololobova, Xin Guo, Tina Yi-Ting Huang, Vijay Ramu, Varen Talwar, Elizabeth E. Wicks, Shaima Salman, Daiana Drehmer, Dominic Dordai, Qiaozhu Zuo, Kenneth W. Witwer, Kathleen L. Gabrielson, Gregg L. Semenza
View: Text | PDF
Research Article Oncology Vascular biology

HIF-1 promotes murine breast cancer brain metastasis by increasing production of integrin β3–containing extracellular vesicles

  • Text
  • PDF
Abstract

Brain metastasis is a major cause of breast cancer (BC) mortality, but the cellular and molecular mechanisms have not been fully elucidated. BC cells must breach the blood-brain barrier in order to colonize the brain. Here, we determined that integrin β3 (ITGB3) expression mediated by hypoxia-inducible factor 1 (HIF-1) plays a critical role in metastasis of BC cells to the brain. Hypoxia stimulated BC cell migration and invasion ex vivo and brain colonization in vivo. Knockdown of either HIF-1α or ITGB3 expression impaired brain colonization by human or mouse BC cells injected into the cardiac left ventricle. Exposure of BC cells to hypoxia increased expression of ITGB3 and its incorporation into small extracellular vesicles (EVs). EVs harvested from the conditioned medium of hypoxic BC cells showed increased retention in the brain after intracardiac injection that was HIF-1α and ITGB3 dependent. EVs from hypoxic BC cells showed binding to brain endothelial cells (ECs), leading to increased EC–BC cell interaction, increased vascular endothelial growth factor receptor 2 signaling, increased EC permeability, and increased transendothelial migration of BC cells. Taken together, our studies implicate HIF-1–stimulated production of ITGB3+ EVs as a key mechanism by which hypoxia promotes BC brain metastasis.

Authors

Yongkang Yang, Chelsey Chen, Yajing Lyu, Olesia Gololobova, Xin Guo, Tina Yi-Ting Huang, Vijay Ramu, Varen Talwar, Elizabeth E. Wicks, Shaima Salman, Daiana Drehmer, Dominic Dordai, Qiaozhu Zuo, Kenneth W. Witwer, Kathleen L. Gabrielson, Gregg L. Semenza

×

Figure 2

ITGB3 is a direct HIF-1 target gene.

Options: View larger image (or click on image) Download as PowerPoint

ITGB3 is a direct HIF-1 target gene.
(A and B) ITGB3 mRNA and protein w...
(A and B) ITGB3 mRNA and protein were analyzed by RT-qPCR (A) and immunoblot assays (B) in 4T1 and 4T1-BR5 cells exposed to 20% or 1% O2. ITGB3 mRNA was quantified relative to 18S rRNA and normalized to mean for 4T1 cells at 20% O2; mean ± SD (n = 3). ****P < 0.0001 vs. 4T1 at 20% O2; ####P < 0.0001 vs. 4T1 at 1% O2 (unpaired 2-tailed Student’s t test). (C–F) 4T1-BR5 (C and D) or MDA231-BrM2 (E and F) subclones were exposed to 20% or 1% O2, and ITGB3 mRNA or protein levels were analyzed by RT-qPCR (C and E) and immunoblot assays (D and F); mean ± SD (n = 3). ****P < 0.0001 vs. NTC at 20% O2; ####P < 0.0001 vs. NTC at 1% O2 (2-way ANOVA with Tukey’s multiple-comparison test). (G and H) Flow cytometry histograms showing anti-ITGB3 antibody binding to 4T1-BR5 (G) or MDA231-BrM2 (H) cells that were exposed to 20% or 1% O2; mean ± SD (n = 3). ****P < 0.0001 vs. 20% O2. (I) ChIP-Seq analysis revealed 3 matches to the HIF consensus binding site 5′-(A/G)CGTG-3′ or its complement (underlined) under the HIF-1α peak in the ITGB3 gene in MDA231-BrM2 cells using the Integrative Genomics Viewer (IGV) genome browser. (J) MDA231-BrM2 cells were exposed to 20% or 1% O2, and ChIP-qPCR was performed using antibodies against HIF-1α, HIF-1β, or HIF-2α. Primers flanking the nucleotide sequence shown in I were used for qPCR, and results were normalized to the mean result at 20% O2; mean ± SD (n = 3). ****P < 0.0001 vs. 20% O2; ns, not significant (unpaired 2-tailed Student’s t test).

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts